Pharmaceutical Business review

Sinclair Pharma names new vice president of business development

In his new role, Dr Macdonald will be primarily responsible for developing new commercial opportunities for Sinclair with a particular focus on dermatology products.

Dr Macdonald has over 20 years of experience in the pharmaceutical industry with extensive knowledge of the dermatology field, both in the US and throughout the world. He joins Sinclair from Stiefel Laboratories where he was most recently vice president, corporate development progressing from his role as vice president business development with Connetics when that company was acquired by Stiefel.

Dr Macdonald has a PhD in biochemistry from Monash University and a postgraduate diploma from the Business School of Swinburne University in Australia.

Michael Flynn, CEO of Sinclair Pharma, said: “I am very pleased to welcome Dr Macdonald aboard as vice president business development North America & South Pacific. Ross has an excellent track record of success combined with extensive experience in the pharmaceutical industry and knowledge of dermatology. I believe this experience and focus on North America and the South Pacific will further reinforce Sinclair’s internal capabilities and be valuable for generating growth within this important region.”